| Patent | Date |
|---|
Method Of Detecting Tim-3 Using Antibody Molecules To Tim-3
App 20220185883 - Sabatos-Peyton; Catherine Anne ; et al. | 2022-06-16 |
Combination Therapies Comprising Antibody Molecules To Lag-3
App 20220153835 - DRANOFF; Glenn ; et al. | 2022-05-19 |
Combination Therapies Comprising Antibody Molecules To Tim-3
App 20220133889 - Dranoff; Glenn ; et al. | 2022-05-05 |
Method of detecting TIM-3 using antibody molecules to TIM-3
Grant 11,155,620 - Sabatos-Peyton , et al. October 26, 2 | 2021-10-26 |
Method Of Targeting Specific Cell Populations Using Cell-binding Agent Maytansinoid Conjugates Linked Via A Non-cleavable Linker, Said Conjugates And Methods Of Making Said Conjugates
App 20210261683 - CHARI; Ravi V.J. ; et al. | 2021-08-26 |
Antibody molecules to TIM-3 and uses thereof
Grant 10,981,990 - Sabatos-Peyton , et al. April 20, 2 | 2021-04-20 |
Antibody Molecules To Lag-3 And Uses Thereof
App 20210009687 - Triebel; Frederic ; et al. | 2021-01-14 |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said
Grant 10,844,135 - Chari , et al. November 24, 2 | 2020-11-24 |
Antibody Molecules To Pd-1 And Uses Thereof
App 20200339689 - Freeman; Gordon James ; et al. | 2020-10-29 |
Antibody Molecules To Tim-3 And Uses Thereof
App 20200308277 - Sabatos-Peyton; Catherine Anne ; et al. | 2020-10-01 |
Antibody molecules to PD-1 and uses thereof
Grant 10,752,687 - Freeman , et al. A | 2020-08-25 |
Antibody Molecules To Tim-3 And Uses Thereof
App 20200223917 - Sabatos-Peyton; Catherine Anne ; et al. | 2020-07-16 |
Antibody molecules to LAG-3 and uses thereof
Grant 10,711,060 - Triebel , et al. | 2020-07-14 |
Antibody molecules to TIM-3 and uses thereof
Grant 10,472,419 - Sabatos-Peyton , et al. Nov | 2019-11-12 |
Combination Therapies Comprising Antibody Molecules To Lag-3
App 20180340025 - Dranoff; Glenn ; et al. | 2018-11-29 |
Combination Therapies Comprising Antibody Molecules To Pd-1
App 20180222982 - Dranoff; Glenn ; et al. | 2018-08-09 |
Combination Therapies Comprising Antibody Molecules To Tim-3
App 20180207273 - Dranoff; Glenn ; et al. | 2018-07-26 |
Antibody Molecules To Pd-1 And Uses Thereof
App 20180155427 - Freeman; Gordon James ; et al. | 2018-06-07 |
Antibody Molecules To Lag-3 And Uses Thereof
App 20180086830 - Triebel; Frederic ; et al. | 2018-03-29 |
Antibody molecules to LAG-3 and uses thereof
Grant 9,908,936 - Triebel , et al. March 6, 2 | 2018-03-06 |
Antibody molecules to TIM-3 and uses thereof
Grant 9,884,913 - Sabatos-Peyton , et al. February 6, 2 | 2018-02-06 |
Antibody molecules to PD-1 and uses thereof
Grant 9,815,898 - Freeman , et al. November 14, 2 | 2017-11-14 |
Antibody Molecules To Pd-1 And Uses Thereof
App 20170247456 - Freeman; Gordon James ; et al. | 2017-08-31 |
Method Of Targeting Specific Cell Populations Using Cell-binding Agent Maytansinoid Conjugates Linked Via A Non-cleavable Linker, Said Conjugates And Methods Of Making Said Conjugates
App 20170226220 - CHARI; Ravi V.J. ; et al. | 2017-08-10 |
Antibody Molecules To Lag-3 And Uses Thereof
App 20170210804 - Triebel; Frederic ; et al. | 2017-07-27 |
Antibody Molecules To Tim-3 And Uses Thereof
App 20170198041 - Sabatos-Peyton; Catherine Anne ; et al. | 2017-07-13 |
Antibody Molecules To Tim-3 And Uses Thereof
App 20170190777 - Sabatos-Peyton; Catherine Anne ; et al. | 2017-07-06 |
Antibody molecules to PD-1 and uses thereof
Grant 9,683,048 - Freeman , et al. June 20, 2 | 2017-06-20 |
Antibody molecules to TIM-3 and uses thereof
Grant 9,605,070 - Sabatos-Peyton , et al. March 28, 2 | 2017-03-28 |
Antibody Molecules To Lag-3 And Uses Thereof
App 20150259420 - Triebel; Frederic ; et al. | 2015-09-17 |
Antibody Molecules To Tim-3 And Uses Thereof
App 20150218274 - Sabatos-Peyton; Catherine Anne ; et al. | 2015-08-06 |
Antibody Molecules To Pd-1 And Uses Thereof
App 20150210769 - Freeman; Gordon James ; et al. | 2015-07-30 |
Method Of Targeting Specific Cell Populations Using Cell-binding Agent Maytansinoid Conjugates Linked Via A Non-cleavable Linker, Said Conjugates And Methods Of Making Said Conjugates
App 20140154804 - CHARI; Ravi V.J. ; et al. | 2014-06-05 |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
Grant RE44,704 - Chari , et al. January 14, 2 | 2014-01-14 |
Compositions and methods for treating cancer using immunoconjugates and chemotherapeutic agents
Grant RE43,899 - Blattler , et al. January 1, 2 | 2013-01-01 |
Method Of Targeting Specific Cell Populations Using Cell-binding Agent Maytansinoid Conjugates Linked Via A Non-cleavable Linker, Said Conjugates And Methods Of Making Said Conjugates
App 20120226025 - CHARI; Ravi V.J. ; et al. | 2012-09-06 |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
Grant 8,198,417 - Steeves , et al. June 12, 2 | 2012-06-12 |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
Grant 8,163,888 - Steeves , et al. April 24, 2 | 2012-04-24 |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
Grant 8,088,387 - Steeves , et al. January 3, 2 | 2012-01-03 |
Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates and methods of making said conjugates
Grant 7,989,598 - Steeves , et al. August 2, 2 | 2011-08-02 |
Cytotoxic agents comprising taxanes and their therapeutic use
Grant 7,585,857 - Chari , et al. September 8, 2 | 2009-09-08 |
Cytotoxic agents comprising taxanes and their therapeutic use
Grant 7,550,609 - Chari , et al. June 23, 2 | 2009-06-23 |
Cytotoxic agents comprising taxanes and their therapeutic use
Grant 7,528,130 - Chari , et al. May 5, 2 | 2009-05-05 |
Cytotoxic agents comprising taxanes and their therapeutic use
Grant 7,476,669 - Chari , et al. January 13, 2 | 2009-01-13 |
Cytotoxic Agents Comprising Taxanes And Their Therapeutic Use
App 20080027130 - CHARI; Ravi V.J. ; et al. | 2008-01-31 |
Cytotoxic agents comprising taxanes and their therapeutic use
Grant 7,276,499 - Chari , et al. October 2, 2 | 2007-10-02 |
Cytotoxic agents comprising taxanes and their therapeutic use
App 20070197775 - Chari; Ravi V.J. ; et al. | 2007-08-23 |
Cytotoxic agents comprising taxanes and their therapeutic use
App 20070196332 - Chari; Ravi V.J. ; et al. | 2007-08-23 |
Cytotoxic agents comprising taxanes and their therapeutic use
Grant 7,217,819 - Chari , et al. May 15, 2 | 2007-05-15 |
Cytotoxic agents comprising taxanes and their therapeutic use
App 20060122259 - Chari; Ravi V. J. ; et al. | 2006-06-08 |
Cytotoxic agents comprising taxanes and their therapeutic use
App 20060106090 - Chari; Ravi V.J. ; et al. | 2006-05-18 |
Cytotoxic agents comprising taxanes and their therapeutic use
Grant 7,008,942 - Chari , et al. March 7, 2 | 2006-03-07 |
Cytotoxic agents comprising taxanes and their therapeutic use
App 20050272729 - Chari, Ravi V.J. ; et al. | 2005-12-08 |
Cytotoxic agents comprising taxanes and their therapeutic use
App 20040087649 - Chari, Ravi V.J. ; et al. | 2004-05-06 |
Cytotoxic agents comprising taxanes and their therapeutic use
Grant 6,706,708 - Chari , et al. March 16, 2 | 2004-03-16 |
Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
Grant 6,630,579 - Chari , et al. October 7, 2 | 2003-10-07 |
Cytotoxic agents comprising taxanes and their therapeutic use
App 20030004210 - Chari, Ravi V.J. ; et al. | 2003-01-02 |
Cytotoxic agents comprising taxanes and their therapeutic use
Grant 6,436,931 - Chari , et al. August 20, 2 | 2002-08-20 |
Cytotoxic Agents Comprising Taxanes And Their Therapeutic Use
App 20020086897 - Chari, Ravi V. J. ; et al. | 2002-07-04 |
Cytotoxic agents comprising taxanes and their therapeutic use
App 20020013485 - Chari, Ravi V.J. ; et al. | 2002-01-31 |
Cytotoxic agents comprising taxanes and their therapeutic use
Grant 6,340,701 - Chari , et al. January 22, 2 | 2002-01-22 |
Cytotoxic agents comprising modified doxorubicins and daunorubicins and their therapeutic use
App 20010036923 - Chari, Ravi V.J. ; et al. | 2001-11-01 |
Targeted delivery of cyclopropylbenzindole-containing cytotoxic drugs
Grant 5,846,545 - Chari , et al. December 8, 1 | 1998-12-08 |
Cyclopropylbenzindole-containing cytotoxic drugs
Grant 5,585,499 - Chari , et al. December 17, 1 | 1996-12-17 |
Cell binding agent conjugates of analogues and derivatives of CC-1065
Grant 5,475,092 - Chari , et al. December 12, 1 | 1995-12-12 |
Cytotoxic agents comprising maytansinoids and their therapeutic use
Grant 5,416,064 - Chari , et al. May 16, 1 | 1995-05-16 |
Blocked lectins; methods and affinity support for making the same using affinity ligands; and method of killing selected cell populations having reduced non-selective cytotoxicity
Grant 5,395,924 - Blattler , et al. March 7, 1 | 1995-03-07 |
Blocked lectins, methods and affinity support for making same using affinity ligands, and method of killing selected cell populations having reduced nonselective cytotoxicity
Grant 5,239,062 - Blattler , et al. August 24, 1 | 1993-08-24 |
Cytotoxic agents comprising maytansinoids and their therapeutic use
Grant 5,208,020 - Chari , et al. | 1993-05-04 |
Gelonin immunotoxin
Grant 4,888,415 - Lambert , et al. December 19, 1 | 1989-12-19 |
Acid-cleavable compound
Grant 4,764,368 - Blattler , et al. August 16, 1 | 1988-08-16 |
Cell-delivery agent
Grant 4,625,014 - Senter , et al. November 25, 1 | 1986-11-25 |
Acid-cleavable compound
Grant 4,618,492 - Blattler , et al. October 21, 1 | 1986-10-21 |
Acid-cleavable compound, use in protein conjugates and drug delivery systems
Grant 4,569,789 - Blattler , et al. February 11, 1 | 1986-02-11 |
Acid-cleavable compound
Grant 4,542,225 - Blattler , et al. September 17, 1 | 1985-09-17 |
| 